The mechanism of insulin action

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue SUPPL. 3, 1999, Pages 721-731

  Nakae, Jun ^a   Accili, Domenico ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Building 10 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR;

CONFERENCE PAPER; DIABETES MELLITUS; DRUG MECHANISM; DRUG RECEPTOR BINDING; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; INSULIN RESISTANCE; INSULIN TREATMENT; SIGNAL TRANSDUCTION;

GLYCOGEN; HUMANS; INSULIN; INSULIN RESISTANCE; MONOSACCHARIDE TRANSPORT PROTEINS; PROTEIN KINASES; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 0033406390     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Kahn CR. Banting Lecture. Insulin action, diabetogenesis, and the cause of type II diabetes. Diabetes 1994; 43: 1066-1084.
2. White MF. The IRS-signalling system: a network of docking proteins that mediate insulin and interleukin signalling. Mol Cell Biochem 1998; 182: 3-11.
3. Kahn CR. New concepts in the pathogenesis of diabetes mellitus. Adv Intern Med 1996; 41: 285-321.
4. Tavare JM, Siddle K. Mutational analysis of insulin receptor function: consensus and controversy. Biochim Biophys Acta 1993; 1178: 21-39.
5. Burgering BM, Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995; 376: 599-602.
6. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378: 785-789.
7. Kohn AD, Summers SA, Birnbaum MJ, Roth RA. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996; 271: 31372-31378.
8. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 1993; 260: 1953-1955.
9. Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997; 278: 2075-2080.
10. Toker A, Cantley LC. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 1997; 387: 673-676.
11. Kohn AD, Barthel A, Kovacina KS, Boge A, Wallach B, Summers SA, Birnbaum MJ, Scott PH, Lawrence JC Jr, Roth RA. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem 1998; 273: 11937-11943.
12. Kitamura T, Ogawa W, Sakaue H, Hino Y, Kuroda S, Takata M, Matsumoto M, Maeda T, Konishi H, Kikkawa U, Kasuga M. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol Cell Biol 1998; 18: 3708-3717.
13. Farese RV. Protein kinase C. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus. A Fundamental and Clinical Text. Philadelphia-New York: Lippincott Raven, 1996; 187-197.
14. Standaert ML, Galloway L, Karnam P, Bandyopadhyay G, Moscat J, Farese RV. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J Biol Chem 1997; 272: 30075-30082.
15. Najjar SM, Blakesley VA, Calzi SL, Kato H, LeRoith D, Choice CV. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit. Biochemistry 1997; 36: 6827-6834.
16. Liu F, Roth RA. Grb-IR: a SH2-domain-containing protein that binds to the insulin receptor and inhibits its function. Proc Natl Acad Sci USA 1995; 92: 10287-10291.
17. Ribon V, Saltiel AR. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes. Biochem J 1997; 324: 839-845.
18. Danielsen AG, Roth RA. Role of the juxtamembrane tyrosine in insulin receptor-mediated tyrosine phosphorylation of p60 endogenous substrates. Endocrinology 1996; 137: 5326-5331.
19. Leibiger IB, Leibiger B, Moede T, Berggren PO. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell 1998; 1: 933-938.
20. Czech MP. Molecular actions of insulin on glucose transport. Ann Rev Nutr 1995; 15: 441-471.
21. Holman GD, Kasuga M. From receptor to transporter: insulin signalling to glucose transport. Diabetologia 1997; 40: 991-1003.
22. Lawrence JC Jr, Roach PJ. New insights into the role and mechanism of glycogen synthase. Diabetes 1997; 46: 541-547.
23. Printen JA, Brady MJ, Saltiel AR. PTG, a protein phosphatase 1-binding protein with a role in glycogen metabolism. Science 1997; 275: 1475-1478.
24. Degerman E, Leroy MJ, Taira M, Belfrage P, Manganiello V. A role for insulin-mediated regulation of cyclic guanosine monophosphate (cGMP)-inhibited phosphodiesterase in the antilipolytic action of insulin. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus. A Fundamental and Clinical Text. Philadelphia-New York: Lippincott Raven, 1996; 197-205.
25. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 1996; 271: 665-668.
26. Kahn CR, Vicent D, Doria A. Genetics of non-insulin-dependent (type-II) diabetes mellitus. Ann Rev Med 1996; 47: 509-531.
27. Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 1994; 43: 735-740.
28. Reaven GM. Insulin resistance and its consequences: non-insulin-dependent diabetes mellitus and coronary heart disease. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus. A Fundamental and Clinical Text. Philadelphia-New York: Lippincott Raven, 1996; 509-518.
29. Polonsky KS, Sturis J, Bell GI. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 1996; 334: 777-783.
30. Ghosh S, Schork NJ. Genetic analysis of NIDDM. The study of quantitative traits. Diabetes 1996; 45: 1-14.
31. Bonadonna RC, Saccomani MP, Seely L, Zych KS, Ferrannini E, Cobelli C, DeFronzo RA. Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes 1993; 42: 191-198.
32. Bonadonna RC, DelPrato S, Bonora E, Saccomanni MP, Gulli G, Natali A, Frascherra S, Pecori N, Ferrannini E, Bier D, Cobelli C, DeFronzo RA. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 1996; 45: 915-925.
33. Reaven GM. The fourth musketeer - from Alexandre Dumas to Claude Bernard. Diabetologia 1995; 38: 3-13.
34. Ferrannini E, Groop LC. Hepatic glucose production in insulin-resistant states. Diabetes Metab Rev 1989; 5: 711-718.
35. White MF. The IRS-1 signaling system. Curr Opin Genet Dev 1994; 4: 47-54.
36. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocr Rev 1995; 16: 117-142.
37. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993; 342: 828-832.
38. Almind K, Inoue G, Pedersen O, Kahn CR. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. J Clin Invest 1996; 97: 2569-2575.
39. Imai Y, Fusco A, Suzuki Y, Lesniak MA, D'Alfonso R, Sesti G, Bertoli A, Lauro R, Accili D. Variant sequences of insulin receptor substrate-1 in patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1994; 79: 1655-1658.
40. Larner J, Taylor SI, eds. Mechanisms of Insulin Resistance. Special issue of J Basic Clin Physiol Pharmacol 1998; 9: 87-439.